Search results
Results from the WOW.Com Content Network
A potential stock split? Considering this fantastic performance, investors have been wondering whether this big pharma company will launch a stock split. History shows us Lilly is open to such ...
Just as a 2:1 stock split cuts a company’s shares in half, a 4-for-1 stock split divides each share into quarters. In this case, the post-split company will have four times as many outstanding ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
[28] [29] IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles. [ 30 ] [ 31 ] The merger was completed in October and the resulting company was a $17.6 billion company called QuintilesIMS. [ 9 ]
After all, if a company has twice as many shares but half the stock price, the company's total market cap remains the same. ... thus making it a candidate for a stock split. 5. Lam Research. Like ...
The main effect of stock splits is an increase in the liquidity of a stock: [3] there are more buyers and sellers for 10 shares at $10 than 1 share at $100. Some companies avoid a stock split to obtain the opposite strategy: by refusing to split the stock and keeping the price high, they reduce trading volume.
For premium support please call: 800-290-4726 more ways to reach us
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California , United States . [ 2 ]